论文部分内容阅读
目的:观察玻璃体内注射曲安奈德治疗黄斑水肿的疗效。方法:对糖尿病性视网膜病变及视网膜静脉阻塞引起的弥漫性黄斑水肿患者44例50只眼行玻璃体腔内注射曲安奈德,观察治疗效果。结果:32只眼视力提高,14只眼视力提高不明显,4只眼视力无提高,4只眼眼压>21mmHg,用药后正常。荧光素眼底血管造影显示治疗后黄斑水肿减退渗漏消失18只眼(36%),黄斑水肿减轻,渗漏明显减少28只眼(56%),黄斑水肿渗漏不变4眼(8%)。结论:玻璃体内注射曲安奈德治疗糖尿病性视网膜病变及视网膜静脉阻塞引起的黄斑水肿安全、有效。
Objective: To observe the curative effect of vitreous injection of triamcinolone acetonide on macular edema. Methods: 44 cases of diffuse macular edema caused by diabetic retinopathy and retinal vein occlusion were injected intravitreally with triamcinolone acetonide in 50 eyes. The therapeutic effect was observed. Results: Visual acuity increased in 32 eyes, visual acuity in 14 eyes was not obvious, visual acuity in 4 eyes was not increased, intraocular pressure was> 21 mmHg in 4 eyes and normal after treatment. Fluorescein angiography showed edema of 18 eyes (36%), macular edema alleviated, leakage decreased obviously in 28 eyes (56%), macular edema infiltration unchanged in 4 eyes (8%), . Conclusion: Vitreous injection of triamcinolone acetonide is safe and effective in the treatment of diabetic retinopathy and macular edema caused by retinal vein occlusion.